Lexaria Bioscience Corp. Quarterly Operating Lease, Payments in USD from Q4 2020 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Lexaria Bioscience Corp. quarterly/annual Operating Lease, Payments history and growth rate from Q4 2020 to Q4 2023.
  • Lexaria Bioscience Corp. Operating Lease, Payments for the quarter ending November 30, 2023 was $8.96K, a 80% decline year-over-year.
  • Lexaria Bioscience Corp. annual Operating Lease, Payments for 2023 was $44.8K.
  • Lexaria Bioscience Corp. annual Operating Lease, Payments for 2021 was $44K, a 0.43% increase from 2020.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $8.96K -$35.9K -80% Sep 1, 2023 Nov 30, 2023 10-Q 2024-01-12
Q4 2022 $44.8K Sep 1, 2022 Nov 30, 2022 10-Q 2024-01-12
Q4 2020 -$11K Sep 1, 2020 Nov 30, 2020 10-Q 2021-01-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.